// App-Quantinova.ai

200 : Evaluating novel peptide therapeutics targeting pathogenic macrophages in systemic sclerosis

Researchers

Presenter

  • James Stanway

Principal Investigators

  • Bahja Ahmed Abdi

  • Henry Lopez

  • George Martin

  • Richard J Stratton

Medical Centers

  • Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK

  • Murigenics, Murigenics, Vallejo, CA

  • Riptide Bioscience, Riptide Bioscience, Vallejo, CA, USA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Peripheral blood mononuclear cell

  • Colony stimulating factor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved